CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, today announced that the company will be presenting at the CIBC World Markets 17th Annual Healthcare Conference, being held November 6th through 8th. The company’s presentation will take place on Tuesday, November 7th, at 1:15 p.m. EST at the Waldorf Astoria in New York, New York.
